A common European approach to the regulatory testing of Manufactured Nanomaterials [NANoREG]

Last updated on 21-3-2019 by Sébastien Daems
March 1, 2013
February 28, 2017

Financial Source

Service(s) working on this project

Sciensano's project investigator(s):

Partners

In short

The innovative and economic potential of Manufactured Nanomaterials (MNMs) is threatened by limited understanding of MNM safety aspects along the value chains. Substantial efforts have given insights in the toxicity of and exposure to MNMs. However, today’s knowledge is not comprehensive enough for regulatory purposes, answering open questions is urgently required. The outstanding approach of NANoREG will provide the right answers to Society, Industry and the National Regulation and Legislation Authorities.

Project summary

The innovative and economic potential of Manufactured Nano Materials (MNMs) is threatened by a limited understanding of the related Environmental Health and Safety (EHS) issues. While toxicity data is continuously becoming available, the relevance to regulators is often unclear or unproven. The shrinking time to market of new MNM drives the need for urgent action by regulators. NANoREG is the first FP7 project to deliver the answers needed by regulators and legislators on EHS by linking them to a scientific evaluation of data and test methods.
Based on questions and requirements supplied by regulators and legislators, NANoREG will:

  1. provide answers and solutions from existing data, complemented with new knowledge
  2. provide a tool box of relevant instruments for risk assessment, characterisation, toxicity testing and exposure measurements of MNMs
  3. develop, for the long term, new testing strategies adapted to innovation requirements
  4. establish a close collaboration among authorities, industry and science leading to efficient and practically applicable risk management approaches for MNMs and products containing MNMs

The interdisciplinary approach involving the three main stakeholders (Regulation, Industry and Science) will significantly contribute to reduce the risks from MNMs in industrial and consumer products.
NANoREG starts by analysing existing knowledge (from WPMN-, FP- and other projects). This is combined with a synthesis of the needs of the authorities and new knowledge covering the identified gaps, used to fill the validated NANoREG tool box and data base, conform with ECHA’s IUCLID DB structure.
To answer regulatory questions and needs, NANoREG will set up the liaisons with the regulation and legislation authorities in the NANoREG partner countries, establish and intensify the liaisons with selected industries and new enterprises, and develop liaisons to global standardisation and regulation institutions in countries like USA, Canada, Australia, Japan, and Russia.

QR code

QR code for this page URL